When cancer is diagnosed, finding treatment options is the top priority

OncoTarget® Series is our comprehensive genomic profiling solution to identify targeted immunotherapies for advanced cancers–solid tumors or leukemias.

OncoTarget® Series Test Menu

OncoTarget® 500

505-Gene Panel Testing

OncoTarget® Myeloid68

An NGS-Based Test For Myeloid Leukemia

OncoTarget® Liquid

Hematology Molecular Panel

Hematology FISH Panel

Immuno Profile Panel

Your confidence is found within OncoTarget’s
multi-technology platform

MSI and Single Mutations

Sample Collection

Sample Processing

Results

GoPath® Diagnostics Launches FDA-Cleared CGP Test under OncoTarget® 500

OncoTarget®500 genomic profiling identifies tumor-based somatic mutations with high accuracy and sensitivity – single nucleotide variants (SNVs), small insertions and deletions, amplifications, translocations, microsatellite instability (MSI) and tumor mutation burden (TMB). OncoTarget® 500 is designed to be used by qualified healthcare professionals in accordance with professional guidelines in oncology for previously diagnosed cancer patients.

Stay connected